Quick Takeaways
- Peter W. Sonsini has 12 issuer positions tracked on this page.
- Estimated disclosed ownership value: $149,282,699.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Peter W. Sonsini
- Location
- Menlo Park, CA
- Summary
- The estimated net worth of Peter W. Sonsini is at least $149,282,699 dollars as of 22 Dec 2022. Peter W. Sonsini is the 10%+ Owner of Monte Rosa Therapeutics, Inc. and owns shares of Monte Rosa Therapeutics, Inc. (GLUE) stock worth about $146.15M. Peter W. Sonsini is the 10%+ Owner of Trevi Therapeutics, Inc. and owns shares of Trevi Therapeutics, Inc. (TRVI) stock worth about $1.92M. Peter W. Sonsini is the 10%+ Owner of Metacrine, Inc. and owns shares of Metacrine, Inc. stock worth about $1.2M. Peter W. Sonsini is the Director of Robinhood Markets, Inc. and owns shares of Robinhood Markets, Inc. (HOOD) stock worth about $3.3K. Peter W. Sonsini is the 10%+ Owner of Eargo, Inc. and owns shares of Eargo, Inc. stock worth about $2.1K. Peter W. Sonsini is the 10%+ Owner of IonQ, Inc. and owns shares of IonQ, Inc. (IONQ) stock worth about $925. Peter W. Sonsini is the 10%+ Owner of Arcellx, Inc. and owns shares of Arcellx, Inc. (ACLX) stock worth about $663. Peter W. Sonsini is the 10%+ Owner of AVEO PHARMACEUTICALS, INC. and owns shares of AVEO PHARMACEUTICALS, INC. stock worth about $360. Peter W. Sonsini is the 10%+ Owner of Desktop Metal, Inc. and owns shares of Desktop Metal, Inc. stock worth about $40.
- Signature
- /s/ Louis Citron, attorney-in-fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Peter W. Sonsini and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Monte Rosa Therapeutics, Inc. ($146,153,662).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Peter W. Sonsini
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| GLUE | Monte Rosa Therapeutics, Inc. | 10%+ Owner | $146,153,662 | 28 Jun 2021 | ||
| TRVI | Trevi Therapeutics, Inc. | 10%+ Owner | $1,916,875 | 11 Apr 2022 | ||
| MTCR | Metacrine, Inc. | 10%+ Owner | $1,204,731 | 10 Dec 2021 | ||
| HOOD | Robinhood Markets, Inc. | Director | $3,317 | 02 May 2022 | ||
| EAR | Eargo, Inc. | 10%+ Owner | $2,126 | 24 May 2021 | ||
| IONQ, IONQ-WT | IonQ, Inc. | 10%+ Owner | $925 | 16 Nov 2022 | ||
| ACLX | Arcellx, Inc. | 10%+ Owner | $663 | 20 Dec 2022 | ||
| AVEO | AVEO PHARMACEUTICALS, INC. | 10%+ Owner | $360 | 19 Oct 2022 | ||
| DM | Desktop Metal, Inc. | 10%+ Owner | $40 | 08 Jun 2021 | ||
| AKUS | Akouos, Inc. | 10%+ Owner | 30 Nov 2022 | |||
| NEUE | Bright Health Group Inc. | 10%+ Owner | 17 Oct 2022 | |||
| GNCA | GENOCEA BIOSCIENCES, INC. | 10%+ Owner | 24 May 2022 |
Insider Transactions Reported by Peter W. Sonsini:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.